Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check6 days agoChange DetectedThe history now includes Revision: v3.6.2, replacing Revision: v3.6.0, indicating an updated deployment of the record history page.SummaryDifference0.1%

- Check13 days agoChange DetectedSeveral core sections and their version entries were removed from the study record history (e.g., Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Contacts/Locations, Study Design, Recruitment Status), reducing visible trial information in the record.SummaryDifference15%

- Check20 days agoChange DetectedThe history adds that recruitment is closed and updates the record revision to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new revision of the page content. This reflects a small update to the page history metadata without altering study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe latest revision tag in the history is updated to v3.5.4, replacing the previous v3.5.3 tag.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s software revision marker was updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a modification to the trial’s record history.SummaryDifference0.1%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.